Advanced Filters
noise

San Donato Milanese (MI), Italy Clinical Trials

A listing of San Donato Milanese (MI), Italy clinical trials actively recruiting patients volunteers.

Found 928 clinical trials
F FABIO MARTELLI, PhD

Transcriptomic Study of Adult Population With Marfan Syndrome

This project is designed to discover circulating biomarkers for aortic aneurysms in adults affected by Marfan Syndrome (MFS). The first aim is to identify circulating transcripts, protein-coding (mRNA) and not (ncRNAs), which show differential expression between three groups of adult patients affected by MFS, based on: presence or absence of …

18 years of age All Phase N/A
L Letizia Corinna Morlacchi, MD

HHV8 and Solid Organ Transplantation

Solid organ transplant candidates will undergo serological screening for HHV8 at time of listing and transplantation. In the event of a recipient/donor mismatch R-/D+ or in the presence of a seropositive recipient (R+), blood levels of HHV8 DNA will be monitored together with specific IGRA for HHV8.

18 years of age All Phase N/A
A Alessia d'Arma, PhD

Personalized Signature of Chronic Inflammation and Early Aging Predictive of the Comorbidities in Infertile Men

The aim of the project is identify new biomarkers and/or prognostic factors in order to develop personalized strategies to prevent the onset of tumor and/or non tumor comorbidity in infertile men.

18 - 50 years of age Male Phase N/A
V Vincenzo Caccavo, Dr.

Optimizer System With ODOCOR II CCM™ Leads

The objective of the ODOCOR II CCM lead study is to evaluate the safety and useability of the ODOCOR II intra-cardiac lead specifically intended to deliver CCM as an accessory lead to the Optimizer IPG.

18 years of age All Phase N/A
G Gianluca Gaidano, MD

Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy

Observational study aimed at describing the characteristics and outcome of CLL patients who started treatment with venetoclax-based regimens according to the local label outside clinical trials in Italy in a period of time ranging from the start of the Venetoclax Named Patient Program (March 2016) until October 31st, 2021.

18 years of age All Phase N/A
S Stefano Scarano, MD, Research Fellow

Efficacy of Split Gait in the Treatment of Dynamic Asymmetries in Subjects With Pathologic Claudication

Walking on a split-belt treadmill (each of the two belts running at a different speed) imposes an asymmetrical gait, mimicking limping that has been observed in various pathologic conditions. This walking modality has been proposed as an experimental paradigm to investigate the flexibility of the neural control of gait and …

18 - 70 years of age All Phase N/A
E Eustachio Agricola, Professor

Multiparametric Protocol for Assessment of Intraprocedural Result of MITRACLIP Procedure

Quantification of residual mitral regurgitation (MR) after MitraClip may be challenging. Quantitative methods for severity assessment may be inaccurate and recent recommendations suggest an assessment of changes in both hemodynamic and echocardiographic parameters, but an established prospectively validated approach is still lacking.

18 - 99 years of age All Phase N/A
G Gianpaolo Balzano, MD

Extending Indication for Islet Autotransplantation in Pancreatic Surgery

Islet autotransplantation (IAT) is a therapeutic approach used to prevent pancreatogenic diabetes or to reduce the severity of diabetes after a major pancreatectomy. Total pancreatectomy with IAT is being used almost exclusively for treatment of chronic pancreatitis. More recently, indications other than chronic pancreatitis have been reported including IAT after …

18 years of age All Phase N/A
A Arcangelo Prete, MD

Observational Study on Skeletal Ewing's Sarcoma

Observational prospective trial aimed to collect the collect demographic, clinical, surgical, pathological and molecular characteristics and treatment from patients affected by skeletal Ewing Sarcoma

- 49 years of age All Phase N/A
S Stefano Partelli, Professor

Financial Toxicity and Patient-Reported Outcomes in GEP-NEN During Treatment

The aim of this study is to evaluate the financial toxicity reported by Italian patients affected by GEP-NEN during the first year of treatment after diagnosis and its correlations with patient-reported outcomes (PROs) and quality of life (QoL).

18 years of age All Phase N/A

Simplify language using AI